WXXWY and 2269:HK Related Headlines

Go Back

Apr 14, 2026 02:22AM Citi Resumes Wuxi Biologics (2269:HK) (WXXWY) at Buy

Mar 27, 2026 05:52AM Wuxi Biologics (2269:HK) (WXXWY) PT Lowered to HK$47 at JPMorgan

Mar 26, 2026 07:11AM Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$45 at Macquarie

Feb 27, 2026 08:44PM CLSA Reiterates Outperform (2) Rating on Wuxi Biologics (2269:HK) (WXXWY)

Feb 13, 2026 08:43AM Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$51 at JPMorgan

Feb 12, 2026 06:51AM Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$50.54 at Nomura/Instinet

Jan 12, 2026 06:40AM Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$48.50 at CLSA

Dec 23, 2025 06:44AM HSBC Reiterates Buy Rating on Wuxi Biologics (2269:HK) (WXXWY)

Nov 28, 2025 08:22AM Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$37.36 at Nomura/Instinet

Oct 17, 2025 09:11AM Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$33.50 at Goldman Sachs

Sep 27, 2025 02:58AM Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$45 at HSBC

Sep 8, 2025 05:17AM Macquarie Reiterates Outperform Rating on Wuxi Biologics (2269:HK) (WXXWY)

Aug 22, 2025 05:09AM Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$40 at Macquarie

Aug 21, 2025 06:37AM Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$29.30 at Goldman Sachs

Aug 21, 2025 05:57AM Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$37 at JPMorgan

Aug 21, 2025 05:22AM Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$40 at Citi

Aug 21, 2025 05:02AM Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$34.80 at CLSA

Aug 14, 2025 07:08AM Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$36 at JPMorgan

Aug 8, 2025 02:22AM UBS Upgrades Wuxi Biologics (2269:HK) (WXXWY) to Buy

Jul 16, 2025 04:48AM Wuxi Biologics (2269:HK) (WXXWY) PT Lowered to HK$34.23 at Nomura/Instinet

WXXWY and 2269:HK Related Press Releases

Go Back

WXXWY and 2269:HK Related SEC Filings

Go Back